Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis

Gracell Biotechnologies (Shanghai) Co., Ltd. · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
cell-therapy
relapsed/refractory al amyloidosis, azd0120, gc012f, amyloidosis, al amyloidosis, car-t, cell therapy, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 805704
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.